Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
This study has been completed.
First Received: December 31, 2002   Last Updated: July 17, 2008   History of Changes
Sponsor: Eisai Inc.
Information provided by: Eisai Inc.
ClinicalTrials.gov Identifier: NCT00050960
  Purpose

This study evaluates the use of Targretin capsules (bexarotene) in combination with standard chemotherapy for the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) in patients who have not yet received chemotherapy for their lung cancer.


Condition Intervention Phase
Non-Small Cell Lung Cancer
Drug: Targretin capsules
Phase III

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Randomized Phase III Trial Comparing Targretin Capsules/Carboplatin/Paclitaxel Versus Carboplatin/Paclitaxel in Chemotherapy-Naïve Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Resource links provided by NLM:


Further study details as provided by Eisai Inc.:

Enrollment: 612
Study Completion Date: March 2005
Primary Completion Date: July 2004 (Final data collection date for primary outcome measure)
Detailed Description:

This study evaluates the use of Targretin capsules (bexarotene) in combination with Carboplatin and Paclitaxel for the treatment of metastatic non-small cell lung cancer in patients who have not yet received chemotherapy for their lung cancer. Every patient receives a platinum-containing chemotherapy every three weeks for at least four chemotherapy cycles (approximately four months). Half of the patients are randomly assigned to receive Targretin capsules once daily in addition to the chemotherapy. The other half is randomized to receive a standard platinum-containing chemotherapy without Targretin capsules.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Patients must have:

  • Pathologic (histologic or cytologic) confirmation of NSCLC
  • Stage IIIB with malignant pleural effusion or Stage IV disease
  • At least one measurable or evaluable NSCLC lesion that has not been previously irradiated unless radiation therapy was more than three weeks prior to entry in the study and the lesion has been shown to have progressed subsequent to the radiation therapy
  • ECOG performance status 0 or 1
  • Adequate organ system function
  • Fasting serum triglycerides that are within the age-adjusted normal range (or normalized with appropriate intervention such as antilipid therapy prior to the initiation of Targretin capsule therapy).

Patients must be able to complete at least four cycles of combination chemotherapy (i.e., approximately four months)

Patients must not have had:

  • Brain metastasis
  • Prior chemotherapy for NSCLC
  • Prior platinum-based chemotherapy for any indication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00050960

  Hide Study Locations
Locations
United States, Alabama
Montgomery Cancer Center, L.L.C.
Montgomery, Alabama, United States, 36106
United States, Arizona
Arizona Clinical Research Center, Inc.
Tucson, Arizona, United States, 85712
United States, California
Sutter Gould Medical Foundation
Modesto, California, United States, 95355
Sharp Health Care
San Diego, California, United States, 92123
Metropolitan Hematology/Oncology Medical Group
Los Angeles, California, United States, 90057
California Cancer Care, Inc.
Greenbrae, California, United States, 94909
Compassionate Cancer Care Medical Group, Inc.
Fountain Valley, California, United States, 92708
Pacific Coast Hematology/Oncology Medical Group, Inc.
Fountain Valley, California, United States, 92708
Sant P. Chawla, Inc.
LOS ANGELES, California, United States, 90067
Southern California Kaiser Permanente Medical Group
San Diego, California, United States, 92120
Medical Group of North County, Inc., San Diego Cancer Center
Vista, California, United States, 92083
Medical Oncology Care Associates
Orange, California, United States, 92868
Bay Area Cancer Research Group, LLC
Concord, California, United States, 94520
UCSF/Mount Zion Comprehensive Cancer Center
San Francisco, California, United States, 94115
Coast Hematology and Oncology Associates
Long Beach, California, United States, 90806
UCLA Medical Center
Los Angeles, California, United States, 94115
United States, Colorado
Rocky Mountain Cancer Centers - Midtown
Denver, Colorado, United States, 80218
United States, Connecticut
Eastern Connecticut Hematology & Oncology
Norwich, Connecticut, United States, 06360
United States, District of Columbia
Georgetown University Hospital
Washington, District of Columbia, United States, 20007
Washington Cancer Institute
Washington, District of Columbia, United States, 20010
United States, Florida
Oncology and Radiation Associates
Miami, Florida, United States, 33133
University of Florida/Jacksonville
Jacksonville, Florida, United States, 32209
Florida Oncology Associates
Orange Park, Florida, United States, 32073
Florida Cancer Institute
New Port Richey, Florida, United States, 34652
Comprehensive Cancer Care Specialists of Boca Raton
Boca Raton, Florida, United States, 33428
Watson Clinic
Lakeland, Florida, United States, 33805
Cancer Centers of Florida, P.A.
Orlando, Florida, United States, 32806
South Florida Oncology & Hematology Consultants
Plantation, Florida, United States, 33324
United States, Georgia
Medical Oncology Associates of Augusta
Augusta, Georgia, United States, 30901
Georgia Oncology Partners Research & Education Foundation
Marietta, Georgia, United States, 30060
United States, Idaho
St. Luke's/Mountain State Tumor Institute (MSTI)
Boise, Idaho, United States, 83712
United States, Illinois
Lutheran General Cancer Care Center
Park Ridge, Illinois, United States, 60068
Northwest Oncology and Hematology, SC
Elk Grove Village, Illinois, United States, 60007
Oncology/Hematology Associates of Central Illinois, P.C.
Peoria, Illinois, United States, 61602
Hematology Oncology Assoc. of Illinois
Skokie, Illinois, United States, 60077
Weiss Memorial Hospital
Chicago, Illinois, United States, 60640
United States, Indiana
Cancer Care Center
New Albany, Indiana, United States, 47150
Michiana Hematology-Oncology
South Bend, Indiana, United States, 46601
Central Indiana Cancer Centers
Indianapolis, Indiana, United States, 46227
United States, Kansas
Kansas City Oncology and Hematology Group, Kansas City Cancer Centers
Overland Park, Kansas, United States, 66210
United States, Kentucky
Drs. Carroll, Sheth, and Raghavan
Louisville, Kentucky, United States, 40215
United States, Louisiana
APMC
Metairie, Louisiana, United States, 70006
Southwest Oncology Associates
Lafayette, Louisiana, United States, 70503
Louisiana State University Health Sciences Center
New Orleans, Louisiana, United States, 70112
Tulane University Health Sciences Center
New Orleans, Louisiana, United States, 70112
United States, Maryland
Chesapeake Oncology-Hematology Associates
Baltimore, Maryland, United States, 21225
Mercy Medical Center
Baltimore, Maryland, United States, 21202
Associates in Oncology/Hematology PC
Rockville, Maryland, United States, 20850
United States, Massachusetts
Berkshire Hematology Oncology, PC
Pittsfield, Massachusetts, United States, 01201
United States, Michigan
Providence Cancer Institute
Southfield, Michigan, United States, 48075
University of Michigan Medical Center
Ann Arbor, Michigan, United States, 48109
United States, Minnesota
St. Lukes Hospital
Duluth, Minnesota, United States, 55805
Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States, 55407
United States, Missouri
Missouri Cancer Associates
Columbia, Missouri, United States, 65201
United States, Montana
Montana Cancer & Infectious Disease Specialists
Missoula, Montana, United States, 59802
Hematology Oncology Centers of the Northern Rockies
Billings, Montana, United States, 59101
United States, Nevada
Cancer and Blood Specialists of Nevada
Henderson, Nevada, United States, 89014
Nevada Cancer Center
Las Vegas, Nevada, United States, 89109
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
United States, New Jersey
Orange Medical Group
East Orange, New Jersey, United States, 07018
VA New Jersey Health Care System
East Orange, New Jersey, United States, 07018
Somerset Hematology Oncology Associates
Somerset, New Jersey, United States, 08873
University of Medicine & Dentistry of NJ, School of Osteopathic Medicine
Stratford, New Jersey, United States, 08084
Overlook Oncology Center
Summit, New Jersey, United States, 07901
Hematology-Oncology Associates of Northern NJ, PA
Morristown, New Jersey, United States, 07962
United States, New Mexico
San Juan Oncology Associates
Farmington, New Mexico, United States, 87401
United States, New York
Arena Oncology Associates
Great Neck, New York, United States, 11021
Erie Medical Center
Buffalo, New York, United States, 14215
VA Medical Center
Northport, New York, United States, 11768
Columbia Presbyterian Medical Center
New York, New York, United States, 10032
New York Presbyterian Hospital, Weill Medical College of Cornell University
New York, New York, United States, 10021
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263
Cancer Research of Long Island, Inc.
Great Neck, New York, United States, 11023
New York Oncology Hematology, P.C., Riverview Cancer Care Medical Associates
Rexford, New York, United States, 12148
Cancer Institute of Long Island, Inc.
Great Neck, New York, United States, 11023
Broome Oncology, LLC
Johnson City, New York, United States, 13790
New York Oncology Hematology, P.C., Capital District Hematology Oncology Associates
Albany, New York, United States, 12208
South Shore Hematology Oncology Associates, PC
Rockville Centre, New York, United States, 11570
United States, North Carolina
Northwest Carolina Oncology and Hematology, P.A.
Hickory, North Carolina, United States, 28602
Raleigh Hematology Oncology Clinic
Cary, North Carolina, United States, 27511
United States, Ohio
Nashat Y. Gabrail, MD, Inc.
Canton, Ohio, United States, 44718
Dayton Oncology/Hematology Consultants
Dayton, Ohio, United States, 45439
Columbus Community Clinical Oncology Program
Columbus, Ohio, United States, 43206
University of Cincinnati, Barrett Cancer Center
Cincinnati, Ohio, United States, 45219
United States, Oklahoma
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104
Cancer Care Associates - Mercy Campus
Oklahoma City, Oklahoma, United States, 73120
Cancer Care Associates
Tulsa, Oklahoma, United States, 74136
United States, Oregon
Oncology/Hematology, Kaiser Permanente Northwest
Portland, Oregon, United States, 97227
United States, Pennsylvania
Oncology Hematology of Lehigh Valley, PC
Bethlehem, Pennsylvania, United States, 18015
Medical Oncology Associates of Wyoming Valley, PC
Kingston, Pennsylvania, United States, 18704
United States, South Carolina
Santee Hematology/Oncology
Sumter, South Carolina, United States, 29150
WJB Dorn VA Medical Center
Columbia, South Carolina, United States, 29209
Liberty Hematology/Oncology
Columbia, South Carolina, United States, 29203
Cancer Centers of the Carolinas
Seneca, South Carolina, United States, 29672
Charleston Hematology Oncology P.A.
Charleston, South Carolina, United States, 29403
United States, Tennessee
Thompson Cancer Survival Center
Knoxville, Tennessee, United States, 37916
Boston Baskin Cancer Group
Memphis, Tennessee, United States, 38104
United States, Texas
University of Texas, MD Anderson Cancer Center
Houston, Texas, United States, 77030
Lone Star Oncology Consultants, P.A.
Austin, Texas, United States, 78759
Hope Oncology
Richardson, Texas, United States, 75080
Hematology & Oncology Associates of South Texas
San Antonio, Texas, United States, 78229
Cancer Specialists of South Texas, PA
Corpus Christi, Texas, United States, 78412
West Texas Cancer Center
Odessa, Texas, United States, 79761
Texas Oncology, P.A.
Dallas, Texas, United States, 75246
South Austin Cancer Center
Austin, Texas, United States, 78745
Texas Cancer Center at Medical City
Dallas, Texas, United States, 75230
Texas Oncology, P.A.
Arlington, Texas, United States, 76012
Texas Oncology, P.A.
Garland, Texas, United States, 75042
Tyler Cancer Center
Tyler, Texas, United States, 75702
Texas Oncology, P.A.
Fort Worth, Texas, United States, 76104
Texoma Cancer Center
Wichita Falls, Texas, United States, 76310
Allison Cancer Center
Midland, Texas, United States, 79701
United States, Utah
Utah Cancer Specialists
Salt Lake City, Utah, United States, 84106
United States, Virginia
Danville Hematology & Oncology, Inc.
Danville, Virginia, United States, 24541
Virginia Cancer Institute
Richmond, Virginia, United States, 23230
Arlington Fairfax Hematology Oncology
Arlington, Virginia, United States, 22205
Stark MD, PC
Portsmouth, Virginia, United States, 23707
Hematology Oncology Patient Enterprises, Center for Cancer Care
Charlottesville, Virginia, United States, 22902
Virginia Oncology Associates
Norfolk, Virginia, United States, 23502
United States, Washington
Yakima Regional Cancer Care Center, Internal Medicine Associates of Yakima, Inc.
Yakima, Washington, United States, 98902
United States, West Virginia
Morgantown Internal Medicine Group
Morgantown, West Virginia, United States, 26505
Austria
Kaiser-Franz-Josef-Spital
Wien, Austria, A-1100
Allgemeines offentliches Krankenhaus der barmherzigen Schwestern vom Heiligen Kreuz Pneumologie
Wels, Austria, 4600
Sozialmedizinisches Zentrum
Wien, Austria, 1145
Canada, Ontario
Algoma Regional Cancer Program - Sault Area Hospital
Sault Ste. Marie, Ontario, Canada, P6A 2C4
Humber River Regional Hospital
Weston, Ontario, Canada, M9N 1N8
Canada, Quebec
S.M.B.D. Jewish General Hospital
Montreal, Quebec, Canada, H3T 1E2
France
Centre Hospitalier General de la Region Annecienne
Annecy Cedex, France, 47011
DOP International
Creteil, France, 94010
Hopital Saint Anne
Toulon Naval, France, 83800
Centre Hospitalier
Villefranche sur Soane, France, 69655
Service de Pneumology, Hopital Adulte de Brabois
Vandoeuvre les Nancy, France, 54511
CHRU Hopital de Bois Guillaume
Bois Guillaume, France, 76230
Centre Hospitalier du Pays d'Aix
Aix en Provence, Cedex 01, France, 13616
CHU - Hopital Nord
St. Etienne, Cedex 2, France, 42055
Hopital Saint Antoine
Paris, Cedex 12, France, 75571
Centre Hospitalier d'Antibes-Juan-Les-Pins
Antibes Cedex, France, 06606
Hopital de Draguignan
Draguignan, France, 83300
Centre Regional de Lutte contre le Cancer (CRLC), Val d'Aurelle-Paul Lamarque
Montpellier, Cedex 05, France, 34298
Centre Hospitalier General
Gap Cedex, France, 05007
Hopital du Cluzeau
Limoges Cedex, France, 87042
CHU Hopital St. Marguerite
Marseille, Cedex 09, France, 29274
Germany
Aesklepios-Fachkliniken Muchen-Gauting
Gauting, Germany, D-82131
Krankenhaus GroBhansdorf, Zentrum fur Pneumologie und Thoraxchirurgie
GroBhansdorf, Germany, 22927
Ludwig-Maximilians Universitat Munchen
Munchen, Germany, 80336
Charite Universitatsklinikum der Humboldt-Universitat zu Berlin
SchumannstraBe, Berlin, Germany, 10117
Dept. of Internal Medicine, St. Nikolaus-Stiftshospital Andernach
Andernach, Germany, D-56626
Spain
Hospital Universitario Doctor Peset
Valencia, Spain, 46 017
Hospital Clinico Universitario, Servicio Hematologia y Oncologia
Valencia, Spain, 46044
Hospital de Sagunto Servicio de Oncologia
Valencia, Spain, 46520
Hospital Provincial de Castellon
Castellon, Spain, 12002
Hospital Universitario La Fe Servicio de Oncologia
Valencia, Spain, 46018
Hospital Clinico San Carlos
Madrid, Spain, 28040
Hospital Arnau de Villanova, Servicio de Oncologia
Valencia, Spain, 46039
Sponsors and Collaborators
Eisai Inc.
Investigators
Study Director: Mack Mabry, M.D. Ligand Pharmaceuticals
  More Information

Additional Information:
No publications provided

Study ID Numbers: L1069-48
Study First Received: December 31, 2002
Last Updated: July 17, 2008
ClinicalTrials.gov Identifier: NCT00050960     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by Eisai Inc.:
NSCLC
Targretin
Retinoid
Bexarotene

Additional relevant MeSH terms:
Thoracic Neoplasms
Anticarcinogenic Agents
Respiratory Tract Neoplasms
Neoplasms by Histologic Type
Antineoplastic Agents
Physiological Effects of Drugs
Protective Agents
Pharmacologic Actions
Carcinoma
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Lung Neoplasms
Bexarotene
Therapeutic Uses
Lung Diseases
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on November 30, 2009